Abstract: An optical transmission system comprises at least one first connection point and one second connection point arranged to transmit and receive at least one channel signal transmitted via at least one optical means connecting the first connection point and the second connection, wherein each of the at least one channel signal is reversibly configurable to be transmitted in either a first direction or a second direction between the first connection point and the second connection point. A method of transmitting at least one channel signal between a first connection point and a second connection point via at least one optical media in an optical transmission system, wherein each of the at least one channel signal is reversibly configurable to be transmitted in either a first direction or a second direction between the first and the second connection points.

Abstract: Systems and method for high-speed single-pixel quantitative phase contrast optical imaging are provided. This imaging technique can bypass the use of conventional image sensors and their associated speed limitations. The quantitative phase images can be acquired much faster than conventional quantitative phase imaging by a chirped-wavelength-encoding mechanism via wavelength-swept laser sources or optical time-stretch based on optical fibers, without the need for interferometric approaches.

Abstract: Apparatus and methods of use are provided for complex flow imaging and analysis that is non-invasive, accurate, and time-resolved. It is particularly useful in imaging of vascular flow with spatiotemporal fluctuations. This apparatus is an ultrasound-based framework called vector projectile imaging (VPI) that can dynamically render complex flow patterns over an imaging view at millisecond time resolution. The VPI apparatus and methods comprise: (i) high-frame-rate broad-view data acquisition (based on steered plane wave firings); (ii) flow vector estimation derived from multi-angle Doppler analysis (coupled with data regularization and least-squares fitting); and (iii) dynamic visualization of color-encoded vector projectiles (with flow speckles displayed as adjunct).

Abstract: OsACBP5 can be used to enhance tolerance to fungal necrotrophs in genetically modified plants. OsACBP5-overexpressing transgenic Arabidopsis were conferred enhanced tolerance to fungal necrotrophs such as root-infecting necrotroph Rhizoctonia solani and shoot-infecting necrotrophs (Botrytis cinerea and Alternaria brassicicola). Vectors/expression cassettes for conferring tolerance to fungal necrotrophs to plants/plant material are provided. Methods of using OsACBP5 to enhance tolerance to fungal necrotrophs are provided. Plants and plant material with improved tolerance to fungal necrotrophs are also provided. Methods for screening for genes with OsACBP5-like activity are also provided.

Abstract: The present invention relates to the field of applied immunotechnology and medicine. More specifically, it relates to DNA motif vaccine design, glyco-DNA motif vaccine design, and immunogen design for producing antibodies against an epitope of arbitrary sequences or polysaccharide epitope, particularly those epitopes against which it is otherwise very difficult to induce antibodies, such as those of HIV-1. The present invention also relates to immunogen design to induce robust cellular and humoral immunity.

Abstract: The current invention relates to novel platinum(II) based organometallic materials. These materials show high emission quantum efficiencies and low self-quenching constant. Also provided are high efficiency, green to orange emitting organic light-emitting diode (OLED) that are fabricated using platinum(II) based organometallic materials as the light-emitting material. The organometallic materials of the invention are soluble in common solvents; therefore, solution process methods such as spin coating and printing can be used for device fabrication. The devices fabricated from these materials show low efficiency roll-off.

Abstract: Apparatus and methods of use are provided for complex flow imaging and analysis that is non-invasive, accurate, and time-resolved. It is particularly useful in imaging of vascular flow with spatiotemporal fluctuations. This apparatus is an ultrasound-based framework called vector projectile imaging (VPI) that can dynamically render complex flow patterns over an imaging view at millisecond time resolution. The VPI apparatus and methods comprise: (i) high-frame-rate broad-view data acquisition (based on steered plane wave firings); (ii) flow vector estimation derived from multi-angle Doppler analysis (coupled with data regularization and least-squares fitting); and (iii) dynamic visualization of color-encoded vector projectiles (with flow speckles displayed as adjunct).

Abstract: The subject invention provides Coriolus versicolor extracts, pharmaceutical compositions comprising the Coriolus versicolor extracts, methods of preparation, and therapeutic uses thereof. Advantageously, the subject Coriolus versicolor extract has immunomodulatory, anti-tumor, anti-microbial, and antiviral effects. In a preferred embodiment, the subject invention can be used to inhibit the metastatic spread of cancer cells. In certain preferred embodiments, the subject invention can be used to treat glioblastoma multiforme, nasopharyngeal carcinoma, breast carcinoma, lung carcinoma, prostate cancer, and colon carcinoma, as well as bacterial, viral, fungal, protozoan, and/or other microbial infection.

Abstract: Systems and methods for optical pulse stretching or compression in time are provided. An apparatus of the subject invention can operate as an optical dispersive element for optical pulse stretching or compression in time, as well as laser scanning in space. An apparatus can include a spatial disperser arranged to divide a collimated optical pulsed beam into an array of collimated beams with equally spaced angles, a beam shaper configured to control the spreading angle of the beam array, and a cavity to sequentially reflect the individual beams within the beam array. The cavity can include two non-parallel surfaces, such as two non-parallel mirrors.

Abstract: A single-stage AC-DC single-inductor multiple-output (SIMO) LED driver uses a single inductor (L) to drive multiple independent LED strings (341-34n) with Power Factor Correction (PFC). The driver uses a diode bridge (20) to achieve initial AC to DC conversion. The output of the bridge (20) is provided to a buck converter whose output is shared with multiple LED strings by a time division multiplex circuit. Feedback is used to separately control the current supplied to each LED string by using a separate reference for each string and controlling the width of the current pulse provided to a string. Current balancing in every LED string can be achieved with the same voltage reference without the need for additional circuitry.

Abstract: The invention disclosed a compound of general formula (I), a single stereoisomer thereof, a mixture of stereoisomers thereof, and a prodrug, pharmaceutically acceptable salt and metabolite thereof, X1, X2, X3, X4, R1, R2, x, y and z being as defined in the present invention.

Abstract: Compositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may also include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination with an oil and forms a laminate.

Abstract: A method and apparatus for generating droplets with a high level of uniformity in liquid systems that present a low interfacial tension. This method and apparatus utilize the breakup of the dispersed phase in a controlled fashion by periodically varying the pressure that drives the fluids so as to successfully generate emulsions with a good control over the size. The method and apparatus can be used for the formation of simple emulsion or double emulsion where a larger droplet contains one or more smaller droplets.

Abstract: The present invention pertains to antibodies against a novel isoform of human PD1 protein (?42PD1) that contains a 42-nucleotide in-frame deletion in exon 2. The invention also pertains to methods of using the antibodies against ?42PD1 for the treatment for autoimmune disorders. In certain embodiments, the antibodies against ?42PD1 are monoclonal.

Abstract: It is proposed a Method and System for Global Motion Estimation and Compensation. The system operates on two depth maps which contain a reference depth map and a current depth map as well as their associated texture images if available. The system executes four major steps which are feature detection (step 1), global motion compensation (GMC) (step 2), major moving objects (MMO) detection and the estimation of their motion parameters denoted as major motion parameters (MMPs) (step 3), and local motion compensation (LMC) of macroblocks or other coding/prediction units (step 4). The output of the system is the global motion parameters (GMPs), major moving objects (MMOs) and MMPs, the local motion vectors (LMVs), and the coding modes.

Abstract: A method for encoding depth map image involves dividing the image into blocks. These blocks are then classified into smooth blocks without large depth discontinuities and discontinuous blocks with large depth discontinuities. In the discontinuous blocks, depth discontinuities are represented by line segments and partitions. Interpolation-based intra prediction is used to approximate and compress the depth values in the smooth blocks and partitions. Further compression can be achieved with of depth-aware quantization, adaptive de-blocking filtering, scale adaptive block size, and resolution decimation schemes.

Abstract: Described herein are novel platinum(II) emitters. These materials show high emission quantum efficiency, a low self-quenching constant, and are stable in thermal deposition processes. Organic light-emitting diodes (OLEDs) fabricated from these materials can have pure green emission, high efficiency and low efficiency roll-off.

Abstract: The subject invention pertains to probiotic compositions and methods of treating hepatocellular carcinoma (HCC) using the probiotic compositions. The probiotic compositions can inhibit growth of HCC. The probiotic compositions can reduce the risk of HCC. The probiotic compositions include a specific combination of three bacterial compositions: (a) heat-inactivated Lactobacillus rhamnosus GG deposited under accession number ATCC 53103, also known as, Lactobacillus acidophilus (Moro) Hansen and Macquot, (b) viable Escherichia coli Nissle 1917, and (c) heat-inactivated VSL#3®. This combination of bacteria is effective to reduce hepatocellular carcinoma (HCC) growth compared to control growth.

Abstract: The current invention relates to novel platinum(II) based organometallic materials. These materials show high emission quantum efficiencies and low self-quenching constant. Also provided are high efficiency, green to orange emitting organic light-emitting diode (OLED) that are fabricated using platinum(II) based organometallic materials as the light-emitting material. The organometallic materials of the invention are soluble in common solvents; therefore, solution process methods such as spin coating and printing can be used for device fabrication. The devices fabricated from these materials show low efficiency roll-off.

Abstract: Annexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance.